Estimating the potential health economic value of introducing universal opt-out testing for HIV in emergency departments in Italy
Italy faces challenges with late HIV diagnoses, which leads to worse health outcomes and higher healthcare costs. In Italy, the proportion of late diagnoses (i.e., a CD4 count <350 cells/mm3) has increased to 60% in 2020—10% higher than the European average (1). With an estimated 13,000–15,000 undiagnosed HIV cases in Italy, innovative testing strategies are urgently needed Read More >
Improving the NHS Blood Culture Pathway in England
Bloodstream infections (BSI) are common and cause severe disease and death. Blood cultures are used to identify whether patients have a bacterial or fungal BSI and assess whether the microbe will be resistant to any antimicrobial therapies (AMTs) helping clinicians to prescribe AMTs to patients who truly need them. NHS England’s blood culture audit indicated low adherence to best practice guidelines and trusts have raised concerns regarding the resource implications of achieving compliance.
Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland
A cost effectiveness analysis of repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK
Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea
Examining the acceptability of offering STI screening in higher educational settings
Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme
Cost analysis of near patient chlamydia and gonorrhoea screening and treatment in further education/technical colleges
Cluster-randomised feasibility trial of a chlamydia test and treat (TnT) service in further education colleges
Modelling cost-effectiveness of multipathogen POC tests for sexually transmitted infections
